Harvard Bioscience (HBIO) Gross Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 86.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 104.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -67.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 694.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -92.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 156.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -188.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 77.00 |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -221.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -221.00 |
| Dec 31, 2025 | 401.00 |
| Sep 30, 2025 | 1,317.00 |
| Jun 30, 2025 | -56.00 |
| Mar 31, 2025 | -26.00 |
| Dec 31, 2024 | -212.00 |
| Sep 30, 2024 | 312.00 |
| Jun 30, 2024 | 122.00 |
| Mar 31, 2024 | 309.00 |
| Dec 31, 2023 | 83.00 |
| Sep 30, 2023 | 192.00 |
| Jun 30, 2023 | -147.00 |
| Mar 31, 2023 | 659.00 |
| Dec 31, 2022 | 5.00 |
| Sep 30, 2022 | -942.00 |
| Jun 30, 2022 | 303.00 |
| Mar 31, 2022 | -107.00 |
| Dec 31, 2021 | 383.00 |
| Sep 30, 2021 | -26.00 |
| Jun 30, 2021 | 730.00 |